Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR Magic

David S. Pisetsky, MD, PhD  |  Issue: October 2011  |  October 7, 2011

David S. Pisetsky, MD, PhD

Last month, I wrote about braving the threatening wrath of the Icelandic volcano Grímsvötn in order to attend the 2011 European League Against Rheumatism (EULAR) Congress in London. Fortunately, I arrived safely at Heathrow airport and made my way to the ExCel convention center. I want to now share with you some of my impressions from this year’s congress.

An International Flavor

Just as in wine, where an international style prevails—cabernet, tempranillo, and syrah are all made to taste alike whether from Australia or Spain—an international style in medical meetings seems now to prevail. The distinct style and charm of the exhibit hall in EULAR—once a boisterous place of magicians, mimes, and cartoon artists—is fading, and the ambience is converging on that of the United States. Down the hall from EULAR, a convention called the MCM Comic Con was much livelier, featuring anime, manga, games, sci-fi, and cosplay (whatever that is), as thousands of young people decorated and dressed outrageously as comic book heroes—Green Lantern, pirates, X-Men—filled the promenade. I asked one of these people, a young man with purple lipstick and neon hair, why he was there. Looking incredulously at me across a generational chasm, he said, “I’m here to have fun.” “Me, too,” I could have replied, but I demurred.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Tower Bridge on the River Thames in London.
The Tower Bridge on the River Thames in London.

In the big exhibit halls, amidst acres of high-tech displays that glittered and popped with electronic wizardry, there was still espresso (as fine a treatment of jet lag as any) available at the drug company booths. At one of the espresso stations, however, a sign said that people from Vermont and Minnesota were unable to partake of the goodies because state laws prohibit physicians from accepting items even of nominal value lest they started writing prescriptions under the influence. Since it is obvious that I am American, I was expecting to be carded, but happily I did not have to produce my passport or driver’s license to get a little cup of java.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I am, of course, concerned that state legislators think that the monetary value of a cup of espresso (even with a biscotti) could twist the workings of my brain to set me in a frenzy of prescription writing for drugs that my patients do not need. If items worth a dollar or two really can bend a physician’s mind, I think that the Sustainable Growth Rate really needs fixing. All I can say is that I hope that people from the Mayo Clinic were on their best behavior, avoiding any embarrassing international incident if someone was caught with his caffeine up. Most certainly, when it is time to renew your medical license, you do not want to indicate that you were extradited from England for being apprehended for possession of illegal cappuccino.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Education & TrainingEULAR/OtherMeeting ReportsOpinionRheuminationsSpeak Out Rheum Tagged with:EULARMeetingTravel

Related Articles

    Braving a Volcano (and Other Dangers) for EULAR

    September 1, 2011

    Conquering natural disasters and the ExCel to experience global rheumatology

    Basilisks in Rheumatology: The Hunt for Rheumatic Mysteries Shrouded in Enigmas & Wrapped in Puzzles

    June 23, 2020

    What do rheumatology and wizardry have in common? More than you may think. Like basilisks, rheumatic diseases are often elusive and changing in presentation…

    Dr. Harry Spiera Retires after 60 Years in Rheumatology

    April 26, 2018

    When Harry Spiera, MD, stepped out of the New York University School of Medicine in 1958, rheumatology was in its infancy. Obviously, much has changed for both the physician and the specialty over the 58 years between then and his recent retirement. “Early on, rheumatology was the most clinical of the specialties, because the science…

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    August 10, 2016

    Where can you network with more than 16,000 professionals in the field of rheumatology? Where you can hear about promising research and best practices from industry leaders? How can you find out about new treatments and technologies on the horizon? You guessed it—at the 2016 ACR/ARHP Annual Meeting, to be held Nov. 11–16. As if…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences